SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Clinical trial NCT06850103 · RECRUITING
Trial details
- NCT number
- NCT06850103
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-22
- Primary completion
- 2027-12-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.